Urological Cancers

  • Jonathan Waxman

Table of contents

  1. Front Matter
    Pages i-xvi
  2. Prostate Cancer

    1. Front Matter
      Pages 1-1
    2. Sarah Ngan, Jonathan Waxman
      Pages 3-16
    3. Sashi S. Kommu, Rosalind A. Eeles
      Pages 17-30
    4. Joshua Phillips, Freddie C. Hamdy
      Pages 31-40
    5. Danish Mazhar
      Pages 41-47
    6. Mererid Evans, Malcolm D. Mason
      Pages 48-59
    7. Mark A. Underwood, David Kirk
      Pages 60-68
    8. Mark R. Feneley, Roger S. Kirby
      Pages 69-76
    9. Gairin J. Dancey, Jonathan Waxman
      Pages 77-82
    10. Srikala S. Sridhar, Malcolm J. Moore
      Pages 83-94
    11. Danish Mazhar, Roopinder Gillmore
      Pages 104-112
  3. Bladder Cancer

    1. Front Matter
      Pages 113-113
    2. Margaret A. Knowles
      Pages 115-130
    3. Jeremy L. Ockrim, Paul D. Abel
      Pages 131-144
    4. Matthew D. Galsky, Dean F. Bajorin
      Pages 145-155
    5. Sunjay Jain, J. Kilian Mellon
      Pages 156-166
  4. Kidney Cancer

    1. Front Matter
      Pages 167-167
    2. Jeffrey M. Holzbeierlein, J. Brantley Thrasher
      Pages 169-183
    3. Simon Chowdhury, Timothy G. Eisen, Martin Gore
      Pages 184-203
    4. Mayer N. Fishman
      Pages 204-217
  5. Testicular Cancer

    1. Front Matter
      Pages 219-219
    2. Jane Houldsworth, George J. Bosl, R. S. K. Chaganti
      Pages 221-229
    3. Thomas R. Geldart, Graham M. Mead
      Pages 230-242
    4. Gillian L. Smith, Timothy J. Christmas
      Pages 243-251
    5. J. Wolter Oosterhuis, Friedemann Honecker, Frank Mayer, Carsten Bokemeyer, L. H. J. Looijenga
      Pages 252-271
  6. Penile Cancer

    1. Front Matter
      Pages 273-273
    2. T. R. Leyshon Griffiths, J. Kilian Mellon
      Pages 275-282
    3. Rajiv Sarin, Hemant B. Tongaonkar, Reena Engineer
      Pages 283-298
  7. Unusual Urological Tumors

    1. Front Matter
      Pages 299-299
    2. Holger Moch
      Pages 301-308
  8. Back Matter
    Pages 333-342

About this book


Our understanding of the scientific basis for urothelial malignancy has advanced significantly. Studies in prostate cancer, few and far between 20 years ago, have increased and the degree of Government intervention, both in Europe and America, to support work in this field has risen considerably. Interest within the pharmaceutical industry has grown as well, and this has led to the development of new treatment options for all of the urological malignancies and real improvements in remission rates and durations.

This book outlines developments in all areas of urological cancer, bringing together, in one volume, summaries of clinical and molecular advances, which will be invaluable to urologists and oncologists.


Urological Cancer Urological Malignancies Urological Oncology Urological Tumours angiogenesis surgery

Editors and affiliations

  • Jonathan Waxman
    • 1
  1. 1.Faculty of Medicine, Hammersmith CampusImperial College LondonLondonUK

Bibliographic information